Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02129543 · ClinicalTrials.gov registry record
Immune Reconstitution in Stem Cell Transplant Recipients
A clinical trial of Cancer, sponsored by University of Miami.
- Recruiting
- Registry status
- 700
- Enrollment target
- 1
- Study location
NCT02129543 is a study of Cancer that is actively recruiting participants, run by University of Miami. The registered enrollment target is 700 participants, below the 3,490-participant average among 615 other Cancer trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02129543, a study of Cancer, is actively recruiting participants, sponsored by University of Miami.
- RECRUITING
- Registry status
- 700 participants
- Enrollment target
- 1
- Study location
Study Summary
This specimen collection lab protocol will allow the investigators to prospectively study immune reconstitution in patients being treated for hematologic disorders and immune factors affecting graft versus host disease in stem-cell transplant (SCT) patients.
Conditions Studied
Interventions
- PROCEDURE Blood Draw
Study Locations (1)
Florida
- University of Miami - Miami
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 700 participants |
| Start Date | 2012-08-15 |
| Est. Completion | 2026-12-15 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02129543
The ClinicalTrials.gov registry entry for NCT02129543 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 700 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,490-participant average among 615 other Cancer trials with a reported enrollment target (80% lower). The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cancer appearing as the primary indexed condition, and to 1 intervention - of which Blood Draw is the first listed.
NCT02129543 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT02129543 about?
NCT02129543 is a clinical study titled "Immune Reconstitution in Stem Cell Transplant Recipients". This specimen collection lab protocol will allow the investigators to prospectively study immune reconstitution in patients being treated for hematologic disorders and immune factors affecting graft versus host disease in stem-cell transplant (SCT) patients.
What is the current status of trial NCT02129543?
This trial is currently recruiting. The enrollment target is 700 participants. The study started on 2012-08-15. Estimated completion is 2026-12-15.
What conditions does trial NCT02129543 study?
This clinical trial studies the following conditions: Cancer.
What interventions are being tested in trial NCT02129543?
The interventions under investigation include: Blood Draw (PROCEDURE).
Who is sponsoring clinical trial NCT02129543?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02129543 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Registry Study to Evaluate the Clinical Outcome of Cancer Patients and Benign Diseases Treated with Radiation
RECRUITING
-
Treatment of Immune Checkpoint Inhibitor-related Diarrhea and/ or Colitis With Ustekinumab in Cancer Patients
RECRUITING · Phase 2
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
A Natural History Study of Metabolic Sizing in Health and Disease
RECRUITING
-
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
RECRUITING · Phase 1
-
Long-Term Follow-Up of Recipient of Gene Transfer Research
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.